Enovis Corporation Announces Upcoming Investor Conferences
Enovis Corporation (NYSE: ENOV), a leader in innovative medical technology, has recently made an exciting announcement regarding its upcoming participation in significant investor conferences. These events are designed to bolster investor relations and provide deeper insights into the company’s strategies and developments.
Details of Upcoming Conferences
The management team at Enovis, including key figures like Matt Trerotola and Ben Berry, will be hosting discussions at two major investor conferences:
Jefferies London Healthcare Conference
At the Jefferies London Healthcare Conference, Matt Trerotola, the Chair and CEO, along with Ben Berry, the CFO, will lead a fireside chat scheduled for a mid-week slot. This conversation will take place on Wednesday, November 20th, at 12:00 p.m. GMT. This setting promises a great opportunity for both current and prospective investors to understand the company’s vision and innovative solutions that aim to improve patient outcomes.
Evercore 7th Annual HealthCONx Conference
The Evercore 7th Annual HealthCONx Conference will feature Ben Berry as well, who will participate in another fireside chat. His discussion is scheduled for Wednesday, December 4th, at 10:50 a.m. ET. This chat is expected to cover critical financial insights and strategic advancements from Enovis, appealing to a broad audience of investors interested in the healthcare sector.
Access to Webcasts of the Events
Investors interested in attending these discussions can find a link to the live audio webcasts available on Enovis Corporation's website. The site will provide easy access to not just these events but also provide replays, allowing flexibility for those who may not be able to participate live. The information hub can be found in the Investors section under Events and Presentations on their website.
About Enovis Corporation
Enovis Corporation is recognized as a forward-thinking, innovation-driven medical technology company. They focus on the development of clinically distinct solutions that not only facilitate better patient outcomes but also optimize workflows. By combining a culture of continuous improvement with global talent, Enovis offers a comprehensive suite of products, services, and integrated technologies. These innovations play a crucial role in promoting active lifestyles, particularly within the orthopedic field.
As an entity listed on the New York Stock Exchange under the ticker ENOV, Enovis is positioned prominently within the med-tech industry, emphasizing significant research and technological advancements.
Contact for Investor Relations
For any inquiries regarding the upcoming conferences or further information about Enovis Corporation, investors are encouraged to reach out to:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
Email: investorrelations@enovis.com
Frequently Asked Questions
What is the purpose of these conferences?
The conferences aim to facilitate discussions between the management of Enovis Corporation and investors, enhancing understanding of the company's initiatives and market strategies.
How can I access the webcasts for these events?
The live audio webcasts and replays will be accessible through the Enovis Corporation's website in the Investors section.
Who will be participating from Enovis?
Key executives including Matt Trerotola, the CEO, and Ben Berry, the CFO, will lead discussions at the conferences.
When is the Jefferies London Healthcare Conference?
The conference is scheduled for November 20th, at 12:00 p.m. GMT.
What highlights can we expect from these investor conferences?
These events are expected to offer valuable insights into the company's strategic direction, financial health, and new innovations in medical technology.
